Cyclin E in human cancers

FASEB Journal

Volumn 13, Issue 8, 1999, Pages 773-780

  Donnellan, Rory ^a   Chetty, Runjan ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

Cell cycle; CKIs; Cyclin dependent kinase; Cyclins

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; RETINOBLASTOMA PROTEIN;

BREAST CANCER; CELL CYCLE S PHASE; COMPLEX FORMATION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DNA SYNTHESIS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; LEUKEMIA; LUNG CANCER; LYMPHOMA; NEOPLASM; ONCOVIRINAE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SARCOMA; SKIN CANCER; UROGENITAL TRACT CANCER;

EID: 0032923368     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.8.773     Document Type: Review

References (109)

1. Donnellan, R., and Chetty, R. (1998) Cyclin D1 and human neoplasia. J. Clin. Pathol. 51, 1-7
2. Koff, A., Cross, F., Fisher, A., Schumacher, J., Leguellec, K., Philippe, M., and Roberts, J. M. (1991) Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66, 1217-1228
3. Demetrick, D. J., Matsumoto, S., Hannon, G. J., Okamoto, K., Xiong, Y., Zhang, H., and Beach, D. H. (1995) Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3). Cytogenet. Cell Genet. 69, 190-192
4. Sauer, K, and Lehner, C. (1995) The role of cyclin E in the regulation of entry into the S phase (review). Prog. Cell Cycle Res. 1, 125-139
5. Keyomarsi, K., and Herliczek, T. W. (1997) The role of cyclin E in cell proliferation, development and cancer (review). [164 refs] Prog. Cell Cycle Res. 3, 171-191
6. Wimmel, A., Lucibello, F. C., Sewing, A., Adolph, S., and Muller, R. (1994) Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9, 995-997
7. Ohtani, K., DeGregori, J., and Nevins, J. R. (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. U. S. A. 92, 12146-12150
8. Geng, Y., Eaton, E. N., Picon, M., Roberts, J. M., Lundberg, A. S., Gifford, A., Sardet, C., and Weinberg, R. A. (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12, 1173-1180
9. Pierce, A. M., Gimenez-Conti, I. B., Schneider-Broussard, R., Martinez, L. A., Conti, C. J., and Johnson, D. G. (1998) Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. U. S. A. 95, 8858-8863
10. Cordon-Cardo, C. (1995) Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am. J. Pathol. 147, 545-560
11. Resnitzky, D., and Reed, S. I. (1995) Different roles for cyclins Dl and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15, 3463-3469
12. Lundberg, A. S., and Weinberg, R. A. (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18, 753-761
13. Courjal, F., Louason, G., Speiser, P., Katsaros, D., Zeillinger, R., and Theillet, C. (1996) Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int. J. Cancer 69, 247-253
14. Gray-Bablin, J., Zalvide, J., Fox, M. P., Knickerbocker, C. J., DeCaprio, J. A., and Keyomarsi, K. (1996) Cyclin E, a redundant cyclin in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 93, 15215-15220
15. Nielsen, N. H., Emdin, S. O., Cajander, J., and Landberg, G. (1997) Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 14, 295-304
16. Molendini, L., Benassi, M. S., Magagnoli, G., Merli, M., Sollazzo, M. R., Ragazzini, P., Gamberi, G., Ferrari, C., Balladelli, A., Bacchini, P., and Picci, P. (1998) Prognostic significance of cyclin expression in human osteosarcoma. Int. J. Oncol. 12, 1007-1111
17. Li, Z., Hromchak, R., and Bloch, A. (1997) Differential expression of proteins regulating cell cycle progression in growth vs. differentiation. Biochim. Biophys. Acta 1356, 149-159
18. Scott, K. A., and Walker, R. A. (1997) Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer. Br. J. Cancer 76, 1288-1292
19. van Dierst, P., Michalides, R., Jannink, L., van der Valk, P., Peterse, H., de Jong, J., Meijer, C., and Baak, J. (1997) Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am. J. Pathol. 150, 705-711
20. Hirama, T., and Koeffler, H. (1995) The role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86, 841-854
21. Wakasugi, E., Kobayashi, T., Tamaki, Y., Nakano, Y., Ito, Y., Miyashiro, I., Komoike, Y., Miyazaki, M., Takeda, T., Monden, T., and Monden, M. (1997) Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer. J. Clin. Pathol. 50, 407-412
22. Hashimoto, Y., Kohri, K., Kaneko, Y., Morisaki, H., Kato, T., Ikeda, K., and Nakanishi, M. (1998) Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression. J. Biol. Chem. 273, 16544-16550
23. Orend, G., Hunter, T., and Ruoslahti, E. (1998) Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene 16, 2575-2583
24. Wang, H., Shao, N., Ding, Q. M., Cui, J., Reddy, E. S., and Rao, V. N. (1997) BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15, 143-157
25. Somasundaram, K., Zhang, H., Zeng, Y., Hovras, Y., Peng, Y., Zhang, H., Wu, C., Licht, J., Weber, B., and El-Diery, W. (1997) Arrest of the cell cycle by the tumor-suppressor BRCA1 requires the CDK-inhibitor p21 WAF/Cip1. Nature (London) 389, 187-190
26. Lesaca, E. E., Ensley, J. F., and Yeudall, W. A. (1998) Cellular factors may enable squamous carcinoma cells to overcome TGF beta-mediated repression of CDK2 activity. Oral Oncol. 34, 52-57
27. Marches, R., Scheuermann, R. H., and Uhr, J. W. (1998) Cancer dormancy: role of cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgM. Cancer Res. 58, 691-697
28. Tanikawa, M., Yamada, K., Tominaga, K., Morisaki, H., Kaneko, Y., Ikeda, K., Suzuki, M., Kiho, T., Tomokiyo, K., Furuta, K., Noyori, R., and Nakanishi, M. (1998) Potent prostaglandin A1 analogs that suppress tumor cell growth through induction of p21 and reduction of cyclin E. J. Biol. Chem. 273, 18522-18527
29. Desrivieres, S., Volarevic, S., Mercep, L., and Ferrari, S. (1997) Evidence for different mechanisms of growth inhibition of T-cell lymphoma by phorbol esters and concanavalin A. J. Biol. Chem. 272, 2470-2476
30. Wu, X., Rubin, M., Fan, Z., DeBlasio, T., Soos, T., Koff, A., and Mendelsohn, J. (1996) Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene 12, 1397-1403
31. Harvat, B. L., Seth, P., and Jetten, A. M. (1997) The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells. Oncogene 14, 2111-2122
32. Yasui, W., Kudo, Y., Semba, S., Yokozaki, H., and Tahara, E. (1997) Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn. J. Cancer Res. 88, 625-629
33. Erlanson, M., Portin, C., Linderholm, B., Lindh, J., Roos, G., and Landberg, G. (1998) Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas - prognostic implications. Blood 92, 770-777
34. Kwon, T. K., and Nordin, A. A. (1998) Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor. Oncogene 16, 755-762
35. St. Croix, B., Sheehan, C., Rak, J. W., Florenes, V. A., Slingerland, J. M., and Kerbel, R. S. (1998) E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J. Cell Biol. 142, 557-571
36. Sheaff, R. J., Groudine, M., Gordon, M., Roberts, J. M., and Clurman, B. E. (1997) Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11, 1464-1478
37. Yamada, H., Ochi, K., Nakada, S., Takahara, S., Nemoto, T., Sekikawa, T., and Horiguchi-Yamada, J. (1995) Interferon modulates the messenger RNA of G1-controlling genes to suppress the G1-to-S transition in Daudi cells. Mol. Cell. Biochem. 152, 149-158
38. Tiefenbrun, N., Melamed, D., Levy, N., Resnitzky, D., Hoffman, I., Reed, S. I., and Kimchi, A. (1996) Alpha Interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Mol. Cell. Biol 16, 3934-3944
39. Murakami-Mori, K., Mori, S., and Nakamura, S. (1998) Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals. J. Immunol 161, 1694-1704
40. Ikezawa, K., Ohtsubo, M., Norwood, T., and Narayaran, A. (1998) Role of cyclin E and cyclin E-dependent kinase in mitogenic stimulation by cementum-derived growth factor in human fibroblasts. FASEB J. 12, 1233-1239
41. Duronio, R. J., and O'Farrell, P. H. (1995) Developmental control of the G1 to S transition in Drosophila: cyclin E is a limiting downstream target of E2F. Genes Dev. 9, 1456-1468
42. Duronio, R. J., Brook, A., Dyson, N., and O'Farrell, P. H. (1996) E2F-induced S phase requires cyclin E. Genes Dev. 10, 2505-2513
43. Leng, X., Connell-Crowley, L., Goodrich, D., and Harper, J. W. (1997) S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr. Biol. 7, 709-712
44. Lukas, J., Herzinger, T., Hansen, K., Moroni, M. C., Resnitzky, D., Helin, K., Reed, S. I., and Bartek, J. (1997) Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11, 1479-1492
45. Leone, G., DeGregori, J., Sears, R., Jakoi, L., and Nevins, J. R. (1997) Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature (London) 387, 422-426
46. Sala, A., Kundu, M., Casella, I., Engelhard, A., Calabrelta, B., Grasso, L., Paggi, M. G., Giordano, A., Watson, R. J., Khalili, K., and Peschle, C. (1997) Activation of human B-MYB by cyclins. Proc. Natl. Acad. Sci. U. S. A. 94, 532-536
47. Zhao, J., Dynlacht, B., Imai, T., Hori, T., and Harlow, E. (1998) Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev. 12, 456-461
48. Seghezzi, W., Chua, K., Shanahan, F., Gozani, O., Reed, R., and Lees, E. (1998) Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol. Cell. Biol. 18, 4526-4536
49. Zerfass, K., Schulze, A., Spitkovsky, D., Friedman, V., Henglein, B., and Jansen-Durr, P. (1995) Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69, 6389-6399
50. McIntyre, M. C., Ruesch, M. N., and Laimins, L. A. (1996) Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology 215, 73-82
51. Frattini, M. G., Hurst, S. D., Lim, H. B., Swaminathan, S., and Laimins, L. A. (1997) Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. EMBO J. 16, 318-331
52. Cho, N. H., Kim, Y. T., and Kim, J. W. (1997) Correlation between G1 cyclins and HPV in the uterine cervix. Int. J. Gynecol. Pathol. 16, 339-347
53. Martin, L. G., Demers, G. W., and Galloway, D. A. (1998) Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J. Virol. 72, 975-985
54. Mate, J. L., Ariza, A., Roca, X., Lopez, D., Ferrandiz, C., Perez-Pileira, J., and Navas-Palacios, J. J. (1998) expression patterns of cyclins D1 and E in condyloma acuminatum in comparison with psoriatic proliferative lesions. J. Pathol. 184, 83-88
55. Quade, B., Park, J., Crum, C., Sun, D., and Dutta, A. (1998) In vivo cyclin E expression as a marker for early cervical neoplasia. Mod. Pathol. 11, 1238-1246
56. Jones, D. L., Alani, R. M., and Munger, K. (1997) The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21 Cp1-mediated inhibition of cdk2. Genes Dev. 11, 2101-2111
57. Chen, I. T., Akamatsu, M., Smith, M. L., Lung, F. D., Duba, D., Roller, P. P., Fornace, A. J., Jr., and O'Connor, P. M. (1996) Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 12, 595-607
58. Ruesch, M. N., and Laimins, L. A. (1997) Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J. Virol. 71, 5570-5578
59. Bresnahan, W. A., Boldogh, I., Thompson, E. A., and Albrecht, T. (1996) Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224, 150-160
60. Swanton, C., Mann, D. J., Fleckenstein, B., Neipel, F., Peters, G., and Jones, N. (1997) Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature (London) 390, 184-187
61. Sakaida, H., Kawamata, S., Hattori, T., and Uchiyama, T. (1998) V3 loop of human immunodeficiency virus type 1 reduces cyclin E expression and induces G1 arrest in interleukin 2-dependent T cells. AIDS Res. Hum. Retrovirus 14, 31-38
62. Kundu, M., Sharma, S., De, L. A., Giordano, A., Rappaport, J., Khalili, K., and Amini, S. (1998) HIV-1 Tat elongates the G1 phase and indirectly promotes HIV-I gene expression in cells of glial origin. J Biol. Chem. 273, 8130-8136
63. Kitahara, K., Yasui, W., Kuniyasu, H., Yokozaki, H., Akama, Y., Yunotani, S., Hisatsugu, T., and Tahara, E. (1995) Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int. J. Cancer 62, 25-28
64. Akama, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Kitahara, K., Ishikawa, T., and Tahara, E. (1995) Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res. 86, 617-621
65. Marone, M., Scambia, G., Giannitelli, C., Ferrandina, G., Masciullo, V., Bellacosa, A., Benedetti-Panici, P., and Mancuso, S. (1998) Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression. Int. J. Cancer 75, 34-39
66. Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., and Roberts, J. M. (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients [see comments]. Nature Med. 3, 222-225
67. Sewing, A., Ronicke, V., Burger, C., Funk, M., and Muller, R. (1994) Alternative splicing of human cyclin E. J. Cell Sci. 107, 581-588
68. Mumberg, D., Wick, M., Burger, C., Haas, K., Funk, M., and Muller, R. (1997) Cyclin ET, a new splice variant of human cyclin E with a unique expression pattern during cell cycle progression and differentiation. Nucleic Acids Res. 25, 2098-2105
69. Aoyagi, K., Koufuji, K., Kodama, I., Yano, S., Ohta, J., Takamiya, H., Mizutani, K., Murakami, N., Takeda, J., Shirouzu, K., and Nakashima, A. (1997) The significance of p21 expression in gastric cancer [Japanese]. Gan to Kagaku Ryoho [Jpn. J. Cancer Chemother] 2, 285-291
70. Nakamura, M., Katano, M., Fujimoto, K., and Morisaki, T. (1997) A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopie biopsy specimens. Ann. Surg. 226, 35-42
71. Bito, T., Ueda, M., Ito, A., and Ichihashi, M. (1997) Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions. J. Cutaneous Pathol. 24, 305-308
72. Stanta, G., Bonin, S., Losi, L., and Eusebi, V. (1998) Molecular characterization of intraductal breast carcinomas. Virchows Arch. 432, 107-111
73. Lu, X., Toki, T., Konishi, I., Nikaido, T., and Fujii, S. (1998) Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis. Cancer 82, 2409-2417
74. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H. J., and Pardee, A. B. (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res. 54, 380-385
75. Dutta, A., Chandra, R., Leiter, L. M., and Lester, S. (1995) Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 92, 5386-5390
76. Nielsen, N. H., Arnerlov, C., Emdin, S. O., and Landberg, G. (1996) Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br. J. Cancer 74, 874-880
77. Catzavelos, C., Bhattacharya, N., Ung, Y., Wilson, J., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., Franssen, E., Pritchard, K., and Slingerland, J. (1997) Decreased levels of the cell-cycle inhibitor p27 protein: prognostic implications in primary breast cancer. Nature Med. 3, 227-230
78. Tahara, E. (1995) Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis [review] [57 refs]. Cancer 75, 1410-1417
79. Sasaki, H., Ishizuka, T., Igaki, H., and Terada, M. (1996) Mutation frequency of the p16/CDKN2 gene and amplifica-tion of the cyclin E gene in human primary gastric carcinomas [review] [17 refs] [Japanese]. Nippon Rinsho -Jpn. J. Clin. Med. 54, 1049-1053
80. Ahn, M., Kim, B. Jang, S., Hong, E., Lee, W., Baik, H., Park, H., Lee, C., and Ki, M. (1998) Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance. J. Korean Med. Sci. 13, 513-518
81. Sakaguchi, T., Watanabe, A., Sawada, H., Yamada, Y., Yamashita, J., Matsuda, M., Nakajima, M., Miwa, T., Hirao, T., and Nakano, H. (1998) Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 82, 1238-1243
82. Wang, A., Yoshimi, N., Suzui, M., Yamauchi, A., Tarao, M., and Mori, H. (1996) Different expression patterns of cyclins A, D1 and E in human colorectal cancer. J. Cancer Res. Clin. Oncol. 122, 122-126
83. Yasui, W., Kuniyasu, H., Yokozaki, H., Semba, S., Shimamoto, F., and Tahara, E. (1996) Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch. 429, 13-19
84. Scuderi, R., Palucka, K. A., Pokrovskaja, K., Bjorkholm, M., Wiman, K. G., and Pisa, P. (1996) Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage [published erratum appears in Blood 1996 Nov 15; 88: 4083]. Blood 87, 3360-3367
85. Volm, M., Koomagi, R., Stammler, G., Rittgen, W., Zintl, F., and Sauerbrey, A. (1997) Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p161NK4A) in childhood acute lymphoblastic leukemia. Int. J. Cancer 74, 508-512
86. Mu, Z. M., Le, X. F., Vallian, S., Glassman, A. B., and Chang, K. S. (1997) Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18, 2063-2069
87. Iida, H., Towatari, M., Tanimoto, M., Morishita, Y., Kodera, Y., and Saito, H. (1997) Overexpression of cyclin E in acute myelogenous leukemia. Blood 90, 3707-3713
88. Wolowiec, D., Benchaib, M., Pernas, P., Deviller, P., Souchier, C., Rimokh, R., Felman, P., Bryon, P. A., and Ffrench, M. (1995) Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia 9, 1382-1388
89. Kanai, M., Shiozawa, T., Xin, L., Nikaido, T., and Fujii, S. (1998) Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 82, 1709-1719
90. Ito, K., Sasano, H., Yoshida, Y., Sato, S., and Yajima, A. (1998) Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma. Anticancer Res. 18, 1661-1664
91. Li, S. F., Shiozawa, T., Nakayama, K., Nikaido, T., and Fujii, S. (1996) Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Cancer 77, 321-329
92. Shiozawa, T., Li, S. F., Nakayama, K., Nikaido, T., and Fujii, S. (1996) Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol. Hum. Reprod. 2, 745-752
93. Ahn, H., Kwon, K., Choi, Y., and Cho, N. (1998) Expression of cyclin E and cyclin-dependent kinase inhibitor, p27 in uterine endometrial carcinoma: relationship with p53 status. Int. J. Surg. Pathol. 6, 205-212
94. Furihata, M., Ohtsuki, Y., Sonobe, H., Shuin, T., Yamamoto, A., Terao, N., and Kuwahara, M. (1998) Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter. Br. J. Cancer 77, 783-788
95. Osman, I., Scher, H., Zhang, Z., Soos, T., Hamza, R., Eissa, S., Khaled, H., Koff, A., and Cordon-Cardo, C. (1997) Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer. Clin. Cancer Res. 3, 2247-2251
96. Corroyer, S., Maitre, B., Cazals, V., and Clement, A. (1996) Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes. J. Biol. Chem. 271, 25117-25125
97. Langenfeld, J., Lonardo, F., Kiyokawa, H., Passalaris, T., Ahn, M. J., Rusch, V., and Dmitrovsky, E. (1996) Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation [published erratum appears in Oncogene 1996 Dec 19; 13: 2743]. Oncogene 13, 1983-1990
98. Sirzen, F., Heiden, T., Nilsson, A., Bergh, J., Skog, S., and Lewensohn, R. (1997) Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities. Anticancer Res. 17, 3381-3386
99. Zhang, S. Y., Liu, S. C., Goodrow, T., Morris, R., and Klein-Szanto, A. J. (1997) Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically in-duced mouse skin neoplasms. Mol. Carcinogen. 18, 142-152
100. Li, W. W., Cordon-Cardo, C., Chen, Q., Jhanwar, S. C., and Bertino, J. R. (1996) Establishment, characterization and drug sensitivity of four new human soft tissue sarcoma cell lines. Int. J. Cancer 68, 514-519
101. Smith, E., Frenkel, B., MacLachlan, T. K., Giordano, A., Stein, J. L., Lian, J. B., and Stein, G. S. (1997) Post-proliferative cyclin E-associated kinase activity in differentiated osteoblasts: inhibition by proliferating osteoblasts and osteosarcoma cells. J. Cell. Biochem. 66, 141-152
102. Dirks, P. B., Hubbard, S. L., Murakami, M., and Rutka, J. T. (1997) Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines. J. Neuropathol. Exp. Neurol. 56, 291-300
103. Patel, V., Jakus, J., Harris, C. M., Ensley, J. F., Robbins, K. C., and Yeudall, W. A. (1997) Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck. Int. J. Cancer 73, 551-555
104. Lazzereschi, D., Sambuco, L., Carnovale, S. C., Ranieri, A., Mincione, G., Nardi, F., and Colletta, G. (1998) Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas. Int. J. Cancer 16, 806-811
105. Wang, S., Wuu, J., Savas, L., Patwardhan, N., and Khan, A. (1998) The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Hum. Pathol. 29, 1304-1309
106. Lauper, N., Beck, A., Cariou, S., Richman, L., Hofmann, K., Reith, W., Slingerland, J., and Amati, B. (1998) Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene 17, 2637-2643
107. Zariwala, M., Liu, J., and Xiong, Y. (1998) Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene 17, 2787-2798
108. Gudas, J., Payton, M., Thukral, S., Chen, E., Bass, M., Robinson, M., and Coats, S. (1999) Cyclin E2, a novel cyclin that binds cdk2 and is aberrantly expressed in human cancers. Mol. Cell. Biol. 19, 612-622
109. Elledge, S. J., and Harper, J. W. (1998) The role of protein stability in the cell cycle and cancer. Biochim. Biophys. Acta 1377, M61-M70